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ABSTRACT 
The aim of the present study was to assess the efficacy of a ready-to-use injectable bone 
substitute on the prevention of alveolar ridge resorption after tooth extraction. Maxillary and 
mandibular premolars were extracted from 3 Beagle dogs with preservation of alveolar bone. 
Thereafter, distal sockets were filled with an injectable bone substitute (IBS), obtained by 
combining a polymer solution and granules of a biphasic calcium phosphate (BCP) ceramic. As a 
control, the mesial sockets were left unfilled. After a 3 months healing period, specimens were 
removed and prepared for histomorphometric evaluation with image analysis. Histomorphometric 
study allowed to measure the mean and the maximal heights of alveolar crest modifications. Results 
always showed an alveolar bone resorption in unfilled sockets. Resorption in filled maxillary sites 
was significantly lower than in control sites. Interestingly, an alveolar ridge augmentation was 
measured in mandibular filled sockets including 30 % of newly-formed bone. It was concluded that 
an injectable bone substitute composed of a polymeric carrier and calcium phosphate can 
significantly increase alveolar ridge preservation after tooth extraction. 
Keywords : Animal Model; Calcium Phosphates; Alveolar Ridge Resorption; In Vivo Test; 
Osteoconduction; Scaffold. 
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INTRODUCTION 
Following tooth extraction, a blood clot develops into the socket and finally leads to new-
bone formation.[1] However, this healing process never allows an ad integrum restitution of the 
initial alveolar bone volume because a physiological resorption systematically conduct to a decrease 
of height and width of alveolar ridge.[2, 3] The resulting alveolar bone loss may generate difficulties 
to ensure long-term stability of conventional or implant-borne prosthetic restoration for partially or 
totally toothless patients.[4] Therefore, various techniques have been proposed to limit alveolar bone 
loss, such as atraumatic extraction,[5] immediate postextraction removable prosthesis,[6] immediate 
placement of dental implant[7, 8] or immediate bone filling of extraction socket.[9-11] Among the 
numerous available filling materials used to prevent alveolar crest resorption,[12-14] allografts and 
xenografts have shown limits because they sometimes generate problems of supply and risks of 
crossed contamination.[15, 16] To overcome these limits, many synthetic bone substitutes were 
proposed among which biphasic calcium phosphates (BCP), associations of hydroxyapatite (HA) 
and beta-tricalcium phosphate (ß-TCP).[17, 18] Calcium phosphate offer a great potential for bone 
regeneration since they have chemical composition close to the biological apatite of bone 
tissues.[19] BCP is generally prepared as blocks, granules or powders and has already proven its 
efficiency as a bone substitution material in different human applications.[20-22] In addition, 
previous studies showed that the granulated form of calcium phosphate ceramics gives satisfactory 
results for alveolar bone regeneration.[23, 24] However, particles present difficulties for placement 
into exiguous sites such as dental sockets. In order to improve their handling, BCP granules have 
been associated to a high viscosity polymer solution to form a ready-to-use injectable bone 
substitute (IBS).[25-28] Previous animal studies conducted in our laboratory have clearly 
demonstrated the biocompatibility and the osseoconductive properties of IBS.[29-31] In the present 
work, we investigated the biofonctionnality and the influence of IBS on alveolar ridge preservation 
H
AL author m
anuscript    inserm
-00176538, version 1
  4 
after tooth extraction. A comparative histomorphometric study was performed on fresh extraction 
sockets. Distal sockets were filled by IBS. As a control, mesial sockets were left unfilled to observe 
a physiological healing process. 
MATERIALS AND METHODS 
Injectable bone substitute 
The biomaterial used in this study was a composite combining an hydrophilic polymer in 
solution and a calcium phosphate mineral phase.[25, 28, 32, 33] 
Polymeric phase 
The polymeric phase was a cellulose derivative (hydropxypropylmethylcellulose = HPMC 
Benecel® MP824, Aqualon, Rueil-Malmaison, France) provided as dry powder. A solution of 2% 
HPMC was prepared by dissolving raw dry HPMC powder in sterile bi-distilled water under stirring 
for 3 days at 20°C. 
Mineral phase 
IBS mineral phase, composed of BCP granules with a 60/40 HA/ ß-TCP weight ratio, was 
obtained by alcaline hydrolysis of commercial dicalcium phosphate dihydrate. The resulting 
precipitated was dried to obtain a calcium deficient apatite powder.[34] Thereafter, this powder was 
humidified to realise a wet granulation (sifters 200-500 µm). Finally, powders have been 
transformed into ceramic after sintering at 1,150°C. BCP granulometry, alone and in association 
with HPMC, was controlled with a laser diffraction granulometer (LS230, Coulther, Miami, USA) 
Composite : IBS 
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IBS was finally obtained by mixing the 2 % HPMC  solution with BCP granules in a 50/50 weight 
ratio. Thereafter, IBS was put into ready-to-use injectors (Merck Eurolab, Fontenay-sous-Bois, 
France) (figure 1), and sterilised by steam at 121°C for 21 minutes (Kavoclave, Kavo, Warthausen, 
Germany). The diameter of the cannula was 2 mm. Before implantation, rheologic properties of IBS 
were controlled with viscosity analyser (DV-I+, Brookfield, Middleboro, USA) and texture analyser 
(TA TX2, Rheo, Champlan, France) . 
Animal experiments 
Surgical procedure 
Three beagle dogs were used for animal experiments. They were 4-year old and respectively 
weighted 12, 13 and 15 kg. Animals were bred for biomedical studies and kept at the National 
Veterinary School of Nantes according to European Community guidelines for the care and use of 
laboratory animals (DE/86/609/CEE). Vaccine calendars of animals were checked and quarantine 
was installed after animal receptions. Teeth were scaled and polished 3 days before implantations. 
General anaesthesia was performed with 12.5 mg/kg intravenous sodium thiopental 
(Nesdonal, Merial, Lyon, France) followed by volatile anaesthesia with halotane (1%). During 
surgery, animals received lactated Ringer’s solution intravenously (15 to 20 ml/kg/h) and 1g of 
cephalosporin (Cefaloject, Bristol Laboratories, Paris, France). 
For each animal, 6 mandibular premolar teeth (figure 2a), and 4 maxillary premolar teeth 
were extracted. Animal experiments were performed on 36 mandibular sockets and 24 maxillary 
sockets (dog premolars present 2 roots: 1 mesial + 1 distal). 
Sulcular incisions were performed mesially from the canine and distally to the molar and full-
thickness buccal and lingual muccoperiosteal flaps were raised. Thereafter, vertical interradicular 
sections were conducted before each root was mobilised and extracted. All alveolar sites were 
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checked and debrided with a surgical curette (figure 2b). After saline solution irrigation, alveolar 
fillings were performed with IBS in distal sockets only (figure 2c). As control mesial sockets were 
left unfilled. Finally, overlapping hermetic sutures (Mersuture® Dec 2, Ethicon, Jansen-Cilag, Issy-
les-Moulineaux, France) were performed to protect operative sites (figure 2d). 
Antibiotic treatment (cephalosporin, 30 mg/kg/j) was continued for 48 hours after surgery by 
intramuscular injection. Animals were checked daily and soft consistency diet was given for 15 
days. Sutures were removed 3 weeks after implantation. Then, a normal diet and an every two-days 
control were performed till sacrifice. Animals were sacrificed 13 weeks after implantation by 
intravenous injection (15 ml) of overdosed sodium pentobarbital (Dolethal, Vetoquinol laboratory, 
Lure, France).  
Sample preparation 
After sacrifice, mandibular and maxillary explants were immediately dissected and fixed in 4 
% paraformaldehyde solution. Sockets were individually separated with a diamond saw. Samples 
were dehydrated in graded ethanol (80°, 95°, 100° at 4°C) during 3 days and placed in pure acetone 
for 24 hours at 4°C. Thereafter, two 8-days embeddments were performed in 
glycolmethylmethacrylate resin (GMMA) at –20°C. Finally, inclusions were performed in GMMA 
(4 days at + 4°C). 
Histological evaluation 
GMMA resin blocks samples were cut on a frontal level with a hard tissue microtome 
(Reichert-Jung 2050, Cambridge instruments, Vienna, Austria). The resulting surfaces were coated 
with gold-palladium metallisor (AE1230, EMScope, Ashford, UK) and analyzed in SEM (JSM 
6300, Jeol, Tokyo, Japan) using backscattered electrons (BSE) at 15 kV. 
Histomorphometric study 
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SEM observations were digitalised and binarised in order to carry out a semi-automatic image 
analysis (PC Quantimeter 500MC, Leica, Cambridge, UK). The outline of each socket was 
identified and a tangent vector to the vestibular and lingual corticals was drawn (figure 3). 
Thereafter, image analysis allowed to measure the mean heights (MeH) and the maximal heights 
(MxH) that separated the vector to the summit of alveolar crest. These heights were negatively 
report when alveolar crest forms a concavity with regard to vector (figure 3a) and positively report 
in case of convex relief (figure 3b). 
When MeH and MxH were positive, it was possible to identify a surface (S+) above the 
vector (figure 3b). First of all, S+ was expressed as percentage of the total socket surface (TS). 
Secondly, the components of S+ (artificial colours in the final computerized images indicate the 
different tissue component surfaces: BCP ceramic particles = White, newly-formed bone = grey and 
non-mineralized soft tissues = black (figures 3b) were identified and measured with image analysis. 
Finally, surfaces of the three different components were expressed as a percentage of S+. 
Statistical analysis 
Three observations were successively performed at 1/4 mesial, in the middle and at 1/4 distal 
of each socket. Seven sockets were voluntarily eliminated from the study because of complications 
during surgery. Results were expressed as mean (± SEM) of MeH and MxH. Comparative studies of 
means of the 48 filled mandibular and the 48 unfilled mandibular sections, as well as the 33 filled 
maxillary and the 30 unfilled maxillary observations were performed using one-way analysis of 
variance (ANOVA) followed by a post-hoc test (Fisher’s projected least significant difference) with 
a significance value of p<0,01. 
 
RESULTS 
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Biomaterial characterization 
IBS granulometry  
Laser diffraction showed that BCP granules diameter ranged from 200 to 500 µm. This class 
of particles represents 78% of the total volume of BCP before incorporation in HPMC polymer, 
70% in the composite before sterilisation, 66% in the composite after sterilisation, 65% in the 
composite at the beginning of injection and 64% in the composite at the end of the injection (figure 
4). 
IBS rheologic properties. 
The composite viscosity was 1,950,000 mPa.s. and a strength ranging from 200 to 600g was 
necessary to inject IBS (figure 5). This force allows a not forced injection of the product which 
remains homogeneous for displacements of the piston lower than 15 mm. For displacements of the 
piston higher than 15 mm, the force necessary to the biomaterial extrusion increases quickly to reach 
5,6 kg (data not shown). Thereafter, injection becomes difficult then impossible with demixtion of 
composite. 
Clinical results 
Minor complications were observed during the surgery. One oro-antral fistula was observed. 
In addition, 2 vestibular process and 4 dental roots were fractured. These 7 sockets (3 maxillary and 
4 mandibular) were not retained for further study. No infectious complication happened during the 
postoperative phase. Sutures were removed after a 3 weeks healing period, without any gingival 
inflammation. 
 
SEM evaluations 
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No BCP granules were found in unfilled sites indicating the absence of material migration 
from the filled sites to the control sites. 
For all unfilled sockets, crest collapse was always observed. Alveolar crest presented a 
morphology forming a concavity with relation to the cortical tangent vector (S-). No mineral 
component was detected between alveolar crest and vector (figure 3a and 3b). 
In filled sockets, results were different for maxillary and mandibular sites. In filled and 
unfilled maxillary sockets, slight collapse crest has been systematically observed, but the bone loss 
appeared less important with IBS. In most of filled mandibular sockets, crest contour presented a 
convexity with respect to the vector.  
Quantitative evaluation 
In unfilled sites, there is no significant difference of mean (MeH) and maximal (MxH) height 
values between maxillary and mandibular sites (figure 6). However, IBS induce a significant 
decrease of alveolar crest resorption in the maxillary sockets, respectively 50 % for MeH and 30 % 
for MxH. Interestingly, IBS allowed MeH and MxH to reach positive values in mandibular filled 
sockets with the expression of S+ representing 6 % of the total socket surface. 
Non-mineralised areas occupy 55.30% ±10.79 of the surface above the vector (S+). In 
addition, newly-formed bone and BCP represent respectively 29.90% ±8.92 and 14.90% ±5.25 of 
S+. 
DISCUSSION 
In the present work, we have shown for the first time that an injectable biomaterial, composed 
of a biphasic calcium phosphate and a cellulose derivative polymer, could prevent alveolar crest 
resorption after tooth extraction. 
H
AL author m
anuscript    inserm
-00176538, version 1
  10 
Systematic filling of a non-damaged extraction socket is not justified because dental surgeons 
agree that the physiologic blood clot is one of the best healing material.[1] Nevertheless, after 
trauma or destructive periodontal disease, and in cases of thin alveolar bony-walls with high 
sensibility to postextractional resorption, this physiological healing process improved difficulties to 
support conventional or implant-supported prosthetic restoration.[35, 36] Furthermore, aesthetic and 
functional requirements from the patients are more and more important and can not be fulfilled 
without a sufficient bone volume.[37] To prevent the alveolar bone crest resorption, numerous 
filling biomaterials have been used among which calcium phosphate ceramics: hydroxyapatite (HA) 
and beta-tricalcium phosphate (ß-TCP) which have respectively shown variable results.[38-40] To 
improve HA and ß-TCP physicochemical properties, biphasic calcium phosphate (BCP), an HA/ß-
TCP association, were secondly proposed.[19] When HA, ß-TCP or BCP were used for alveolar 
filling, the best resorption/substitution process were reported with granulated form.[23, 24] To 
overcome the manipulation limits of particles into exiguous tooth sockets, we have recently 
proposed toassociate BCP granules with a polymer solution to provide a ready-to-use injectable 
bone substitute (IBS).[25, 26, 28]. The osteoconductive potential of this innovative biomaterial was 
previously demonstrated for clinical application in our laboratory [29-30] and in the same animal 
model [31] with the quantification of each component, BCP, bone and soft tissue. In an attempt to 
prevent the bone crest resorption after tooth extraction, the present study investigates the efficiency 
of IBS to promote the preservation of the alveolar ridge morphology after filling of fresh extraction 
sockets.  
In a first set of experiments, we sought to confirm whether IBS exhibit handling properties 
compatible with its clinical potential applications as a socket filling material. Controls performed 
before implantation confirmed that IBS presents rheologic properties allowing to obtain a 
homogeneous filling of dental sockets. Injection from the bottom to the top of the socket did not 
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reveal any difficulties. However, the limit in the increase of granule size is the preservation of IBS 
rheologic properties and the 200 to 500 µm particles seems to be the higher diameter appropriate to 
alveolar filling. The homogenisation triggers a reduction of 8 % of calcium phosphate mean size 
particles. However, BCP granulometry in the final product remains in the range of 200-500 µm. To 
strengthen our preliminary data, we are currently conducting studies on IBS with 40 to 80 µm and 
80 to 200 µm diameter BCP granules. 
The main objective of this work was to obtain quantitative results on alveolar bone crest 
resorption. Among the numerous available tools, we choosed the semi-automatic image analysis 
because it allows to analyse quickly and accurately a large amount of informations.[30, 41] 
However, our quantitative data showed some limitations since they were carried out with respect to 
the vestibular and lingual process, which may have been subjected to a post-extraction resorption 
process. Consequently, previous studies carried out on the alveolar resorption after dental extraction 
generally start from a fixed point such as an adjacent tooth or a dental implant.[42-45] Nevertheless, 
this work highlights  the clinical benefice provided by IBS. Most of the previous filling studies 
performed on Beagle dogs[46-48] have only used mandibular sockets, because of the extreme 
difficulty to atraumatically extracted maxillary teeth. In the present work, six mandibular premolar 
teeth and four maxillary premolar teeth were used for each animal to increase the available sockets 
for statistical analysis. Nevertheless, the study of the superior and inferior sockets was voluntarily 
separated in order to evaluate a potential difference between these two sites. To our knowledge, no 
documented research exists to explain our higher results obtained with mandibular sockets. Among 
the explaining causes are: (i) a larger cortical thickness to the mandible, (ii) a major quantity of 
injected material in mandibular sites and finally, (iii) a greater difficulty to carry out histological 
sections in the maxillary. 
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In the filled mandibular sockets, analysis of components of S+ has shown that non-
mineralised areas occupied the half surface of the crest height gain. Two hypothesis can be assumed 
on the future of S+. First of all, since non-mineralised areas are located at the periphery of BCP and 
newly-formed bone, one can think that after BCP substitution, bone healing process will lead to the 
reduction of these non-mineralised areas. One can also assume that BCP and newly-formed bone 
only help on a temporary time the convex crest morphology maintenance. Secondary resorption 
would then be only delayed. Between both hypothesis, it is wise to envisage an intermediary 
alternative for which alveolar filling would enable, not a height gain, but an absence of resorption 
after complete bone healing and BCP resorption/substitution process. This alternative would 
constitute an interesting overhang for conventional or implant-borne prosthetic rehabilitations. 
However, this hypothesis is to be confirmed by further experimentations over longer periods. 
CONCLUSION 
This study demonstrates that a composite biomaterial prevents alveolar crest resorption after 
tooth extraction. The increasing number of partially or completely edentulous patients is in close 
relationship with population aging process. Therefore, more comfortable and durable prosthetic 
rehabilitations are a great challenge for the scientific community. In addition, the approval of 
alveolar bone preservation biomaterials, such as IBS, could make possible the development of 
candidates to oral implantology. In this context, our data open new therapeutic windows for pre-
implant surgery in unfavourable anatomic situations. IBS could be further proposed for human 
clinical applications such as reconstruction of osseous deficiencies, peri-implantitis treatment or 
sinus floor elevations. 
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ILLUSTRATION LEGENDS 
 
Figure 1: Photographs of the ready-to-use injectable bone substitute (IBS) placed into an 
injector. 
 
Figure 2: Photographs of the surgical procedures in Beagle dogs. 
a: second (P2), third (P3) and fourth (P4) left mandibular premolars (preoperative view). 
b: debrided mesial and distal sockets after second, third and fourth premolar extractions. 
c: IBS-filled distal sockets (DS). As control, mesial socket (MS) were left unfilled. 
d: overlapping flaps sutures. 
 
Figure 3: Scanning electron microscopy observations of axial sections of mandibular 
sockets after three month of healing. With backscattered electrons newly formed bone 
appeared in dark grey, BCP ceramic in light grey and soft tissues and bone marrow in 
black (a, b). A tangent vector [white line] to the vestibular and lingual cortical was drawn. 
(bar = 0,5 mm). 
a: unfilled socket. Note the presence of a collapse below the vector (*). 
b: IBS-filled socket. Note the presence of mineralized tissues above the vector (white 
arrows). S+ indicates the alveolar ridge augmentation above the vector (white double 
arrows). 
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Figure 4: Mean particulate size distribution of BCP powder, BCP in IBS before 
sterilisation and in the final injected product. Results were obtained by laser diffraction 
and are expressed as percent of the total volume of particles. 
 
Figure 5: Extrusion of the BCP mixture through a 4-mm hole at a rate of 0.1 mm/sec. 
Compression strength measurements on the piston of an injection syringe were recorded 
with a computer to obtain these profiles. Experiments was repeated three times (test1, 2 
and 3). 
 
Figure 6: Variations of mean heights (MeH) and maximal heights (MxH) that separated 
the vector of the alveolar crest summit after three months of socket healing either in 
control filled maxillary or mandibular sites. Results are expressed in mm [mean ± SEM]. 
*: P < 0,01 as compared to maxillary control. 
#: p < 0,01 as compared to mandibular control. 
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